Market Research Logo

United States Osteoarthritis Pain Drugs Market Report 2017

United States Osteoarthritis Pain Drugs Market Report 2017

This report studies sales (consumption) of Osteoarthritis Pain Drugs in USA market, focuses on top players, with sales, price, revenue, gross margin and market share for each player, covering
Johnson & Johnson
Pfizer
GlaxoSmithKline
Mylan
Lilly
Sanofi
Abbott Laboratories
Bayer
Almatica Pharma
TEVA
Iroko Pharmaceuticals

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Oral
Injection
External

Split by applications, this report focuses on sales, market share and growth rate of Osteoarthritis Pain Drugs in each application, can be divided into
Medical Care
Personal Care


1 Osteoarthritis Pain Drugs Overview
1.1 Product Overview and Scope of Osteoarthritis Pain Drugs
1.2 Classification of Osteoarthritis Pain Drugs
1.2.1 Oral
1.2.2 Injection
1.2.3 External
1.3 Applications of Osteoarthritis Pain Drugs
1.3.1 Medical Care
1.3.2 Personal Care
1.4 USA Market Size Sales (Volume) and Revenue (Value) of Osteoarthritis Pain Drugs (2012-2022)
1.4.1 USA Osteoarthritis Pain Drugs Sales and Growth Rate (2012-2022)
1.4.2 USA Osteoarthritis Pain Drugs Revenue and Growth Rate (2012-2022)
2 USA Osteoarthritis Pain Drugs Competition by Manufacturers
2.1 USA Osteoarthritis Pain Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Osteoarthritis Pain Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 USA Osteoarthritis Pain Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Osteoarthritis Pain Drugs Market Competitive Situation and Trends
2.4.1 Osteoarthritis Pain Drugs Market Concentration Rate
2.4.2 Osteoarthritis Pain Drugs Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 USA Osteoarthritis Pain Drugs Sales (Volume) and Revenue (Value) by Type (2012-2017)
3.1 USA Osteoarthritis Pain Drugs Sales and Market Share by Type (2012-2017)
3.2 USA Osteoarthritis Pain Drugs Revenue and Market Share by Type (2012-2017)
3.3 USA Osteoarthritis Pain Drugs Price by Type (2012-2017)
3.4 USA Osteoarthritis Pain Drugs Sales Growth Rate by Type (2012-2017)
4 USA Osteoarthritis Pain Drugs Sales (Volume) by Application (2012-2017)
4.1 USA Osteoarthritis Pain Drugs Sales and Market Share by Applications (2012-2017)
4.2 USA Osteoarthritis Pain Drugs Sales Growth Rate by Applications (2012-2017)
5 USA Osteoarthritis Pain Drugs Manufacturers Profiles/Analysis
5.1 Johnson & Johnson
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Osteoarthritis Pain Drugs Information
5.1.3 Johnson & Johnson Osteoarthritis Pain Drugs Sales (M Dose), Revenue (M USD), Price (USD/K Dose) and Gross Margin (2012-2017)
5.2 Pfizer
5.2.1 Company Basic Information, Manufacturing Base and Competitors
5.2.2 Osteoarthritis Pain Drugs Information
5.2.3 Pfizer Osteoarthritis Pain Drugs Sales (M Dose), Revenue (M USD), Price (USD/K Dose) and Gross Margin (2012-2017)
5.3 GlaxoSmithKline
5.3.1 Company Basic Information, Manufacturing Base and Competitors
5.3.2 Osteoarthritis Pain Drugs Information
5.3.3 GlaxoSmithKline Osteoarthritis Pain Drugs Sales (M Dose), Revenue (M USD), Price (USD/K Dose) and Gross Margin (2012-2017)
5.4 Mylan
5.4.1 Company Basic Information, Manufacturing Base and Competitors
5.4.2 Osteoarthritis Pain Drugs Information
5.4.3 Mylan Osteoarthritis Pain Drugs Sales (M Dose), Revenue (M USD), Price (USD/K Dose) and Gross Margin (2012-2017)
5.5 Lilly
5.5.1 Company Basic Information, Manufacturing Base and Competitors
5.5.2 Osteoarthritis Pain Drugs Information
5.5.3 Lilly Osteoarthritis Pain Drugs Sales (M Dose), Revenue (M USD), Price (USD/K Dose) and Gross Margin (2012-2017)
5.6 Sanofi
5.6.1 Company Basic Information, Manufacturing Base and Competitors
5.6.2 Osteoarthritis Pain Drugs Information
5.6.3 Sanofi Osteoarthritis Pain Drugs Sales (M Dose), Revenue (M USD), Price (USD/K Dose) and Gross Margin (2012-2017)
5.7 Abbott Laboratories
5.7.1 Company Basic Information, Manufacturing Base and Competitors
5.7.2 Osteoarthritis Pain Drugs Information
5.7.3 Abbott Laboratories Osteoarthritis Pain Drugs Sales (M Dose), Revenue (M USD), Price (USD/K Dose) and Gross Margin (2012-2017)
5.8 Bayer
5.8.1 Company Basic Information, Manufacturing Base and Competitors
5.8.2 Osteoarthritis Pain Drugs Information
5.8.3 Bayer Osteoarthritis Pain Drugs Sales (M Dose), Revenue (M USD), Price (USD/K Dose) and Gross Margin (2012-2017)
5.9 Almatica Pharma
5.9.1 Company Basic Information, Manufacturing Base and Competitors
5.9.2 Osteoarthritis Pain Drugs Information
5.9.3 Almatica Pharma Osteoarthritis Pain Drugs Sales (M Dose), Revenue (M USD), Price (USD/K Dose) and Gross Margin (2012-2017)
5.10 TEVA
5.10.1 Company Basic Information, Manufacturing Base and Competitors
5.10.2 Osteoarthritis Pain Drugs Information
5.10.3 TEVA Osteoarthritis Pain Drugs Sales (M Dose), Revenue (M USD), Price (USD/K Dose) and Gross Margin (2012-2017)
5.11 Iroko Pharmaceuticals
5.11.1 Company Basic Information, Manufacturing Base and Competitors
5.11.2 Osteoarthritis Pain Drugs Information
5.11.3 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales (M Dose), Revenue (M USD), Price (USD/K Dose) and Gross Margin (2012-2017)
6 Osteoarthritis Pain Drugs Manufacturing Cost Analysis
6.1 Osteoarthritis Pain Drugs Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Key Suppliers of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Other Cost Analysis
6.2.4 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Osteoarthritis Pain Drugs
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Osteoarthritis Pain Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Osteoarthritis Pain Drugs Major Manufacturers in 2016
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Economic/Political Environmental and Health Expenditure Analysis
9.1 Economic/Political Environmental Change
9.2 Health Expenditure Analysis
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 USA Osteoarthritis Pain Drugs Market Forecast 2017-2022
11.1 USA Osteoarthritis Pain Drugs Sales, Revenue Forecast 2017-2022
11.2 USA Osteoarthritis Pain Drugs Sales Forecast by Type 2017-2022
11.3 USA Osteoarthritis Pain Drugs Sales Forecast by Application 2017-2022
11.4 Osteoarthritis Pain Drugs Price Forecast 2017-2022
12 Research Findings and Conclusion
13 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Osteoarthritis Pain Drugs
Table Classification of Osteoarthritis Pain Drugs
Figure USA Sales Market Share of Osteoarthritis Pain Drugs by Types in 2016
Figure Oral Picture
Figure Injection Picture
Figure External Picture
Table Applications of Osteoarthritis Pain Drugs
Figure USA Sales Market Share of Osteoarthritis Pain Drugs by Applications in 2016
Figure Medical Care Examples
Figure Personal Care Examples
Figure USA Osteoarthritis Pain Drugs Sales (M Dose) and Growth Rate (2012-2022)
Figure USA Osteoarthritis Pain Drugs Revenue (M USD) and Growth Rate (2012-2022)
Table USA Osteoarthritis Pain Drugs Sales (M Dose) of Key Manufacturers (2015 and 2016)
Table USA Osteoarthritis Pain Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Osteoarthritis Pain Drugs Sales Share by Manufacturers
Figure 2016 Osteoarthritis Pain Drugs Sales Share by Manufacturers
Table USA Osteoarthritis Pain Drugs Revenue (M USD) by Manufacturers (2015 and 2016)
Table USA Osteoarthritis Pain Drugs Revenue Share by Manufacturers (2015 and 2016)
Figure 2015 USA Osteoarthritis Pain Drugs Revenue Share by Manufacturers
Figure 2016 USA Osteoarthritis Pain Drugs Revenue Share by Manufacturers
Table USA Market Osteoarthritis Pain Drugs Average Price (USD/Dose) of Key Manufacturers (2015 and 2016)
Figure USA Market Osteoarthritis Pain Drugs Average Price (USD/Dose) of Key Manufacturers in 2016
Table USA Osteoarthritis Pain Drugs Revenue Share by Manufacturers (2015 and 2016)
Osteoarthritis Pain Drugs Information Revenue Market Share of Top 3 Manufacturers in 2016
Osteoarthritis Pain Drugs Information Revenue Market Share of Top 5 Manufacturers in 2016
Table Mergers & Acquisitions, Expansion
Table USA Osteoarthritis Pain Drugs Sales (M Dose) by Type (2012-2017)
Table USA Osteoarthritis Pain Drugs Sales Share by Type (2012-2017)
Figure USA Osteoarthritis Pain Drugs Sales Market Share by Type in 2015
Figure USA Osteoarthritis Pain Drugs Sales Market Share by Type in 2016
Table USA Osteoarthritis Pain Drugs Revenue (M USD) by Type (2012-2017)
Table USA Osteoarthritis Pain Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Osteoarthritis Pain Drugs by Type in 2015
Figure Revenue Market Share of Osteoarthritis Pain Drugs by Type in 2016
Table USA Osteoarthritis Pain Drugs Price (USD/K Dose) by Types (2012-2017)
Figure USA Osteoarthritis Pain Drugs Sales Growth Rate by Type (2012-2017)
Table USA Osteoarthritis Pain Drugs Sales (M Dose) by Applications (2012-2017)
Table USA Osteoarthritis Pain Drugs Sales Market Share by Applications (2012-2017)
Figure USA Osteoarthritis Pain Drugs Sales Market Share by Applications in 2015
Figure USA Osteoarthritis Pain Drugs Sales Market Share by Applications in 2016
Table USA Osteoarthritis Pain Drugs Sales Growth Rate by Applications (2012-2017)
Figure USA Osteoarthritis Pain Drugs Sales Growth Rate by Applications (2012-2017)
Table Johnson & Johnson Basic Information List
Figure Osteoarthritis Pain Drugs
Table Johnson & Johnson Osteoarthritis Pain Drugs Sales (M Dose), Revenue (M USD), Price (USD/K Dose) and Gross Margin (2012-2017)
Figure Johnson & Johnson Osteoarthritis Pain Drugs Sales (M Dose) and Market Share (2012-2017)
Table Pfizer Basic Information List
Figure Osteoarthritis Pain Drugs
Table Pfizer Osteoarthritis Pain Drugs Sales (M Dose), Revenue (M USD), Price (USD/K Dose) and Gross Margin (2012-2017)
Figure Pfizer Osteoarthritis Pain Drugs Sales (M Dose) and Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Figure Osteoarthritis Pain Drugs
Table GlaxoSmithKline Osteoarthritis Pain Drugs Sales (M Dose), Revenue (M USD), Price (USD/K Dose) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Osteoarthritis Pain Drugs Sales (M Dose) and Market Share (2012-2017)
Table Mylan Basic Information List
Figure Osteoarthritis Pain Drugs
Table Mylan Osteoarthritis Pain Drugs Sales (M Dose), Revenue (M USD), Price (USD/K Dose) and Gross Margin (2012-2017)
Figure Mylan Osteoarthritis Pain Drugs Sales (M Dose) and Market Share (2012-2017)
Table Lilly Basic Information List
Figure Osteoarthritis Pain Drugs
Table Lilly Osteoarthritis Pain Drugs Sales (M Dose), Revenue (M USD), Price (USD/K Dose) and Gross Margin (2012-2017)
Figure Lilly Osteoarthritis Pain Drugs Sales (M Dose) and Market Share (2012-2017)
Table Sanofi Basic Information List
Figure Osteoarthritis Pain Drugs
Table Sanofi Osteoarthritis Pain Drugs Sales (M Dose), Revenue (M USD), Price (USD/K Dose) and Gross Margin (2012-2017)
Figure Sanofi Osteoarthritis Pain Drugs Sales (M Dose) and Market Share (2012-2017)
Table Abbott Laboratories Basic Information List
Figure Osteoarthritis Pain Drugs
Table Abbott Laboratories Osteoarthritis Pain Drugs Sales (M Dose), Revenue (M USD), Price (USD/K Dose) and Gross Margin (2012-2017)
Figure Abbott Laboratories Osteoarthritis Pain Drugs Sales (M Dose) and Market Share (2012-2017)
Table Bayer Basic Information List
Figure Osteoarthritis Pain Drugs
Table Bayer Osteoarthritis Pain Drugs Sales (M Dose), Revenue (M USD), Price (USD/K Dose) and Gross Margin (2012-2017)
Figure Bayer Osteoarthritis Pain Drugs Sales (M Dose) and Market Share (2012-2017)
Table Almatica Pharma Basic Information List
Figure Osteoarthritis Pain Drugs
Table Almatica Pharma Osteoarthritis Pain Drugs Sales (M Dose), Revenue (M USD), Price (USD/K Dose) and Gross Margin (2012-2017)
Figure Almatica Pharma Osteoarthritis Pain Drugs Sales (M Dose) and Market Share (2012-2017)
Table TEVA Basic Information List
Figure Osteoarthritis Pain Drugs
Table TEVA Osteoarthritis Pain Drugs Sales (M Dose), Revenue (M USD), Price (USD/K Dose) and Gross Margin (2012-2017)
Figure TEVA Osteoarthritis Pain Drugs Sales (M Dose) and Market Share (2012-2017)
Table Iroko Pharmaceuticals Basic Information List
Figure Osteoarthritis Pain Drugs
Table Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales (M Dose), Revenue (M USD), Price (USD/K Dose) and Gross Margin (2012-2017)
Figure Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales (M Dose) and Market Share (2012-2017)
Table Osteoarthritis Pain Drugs Raw Material Figure and Suppliers
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Osteoarthritis Pain Drugs
Figure United States Overview of Average Hourly Wages 2015-2016 (USD/Hour)
Figure United States Overview of Labor Costs 2013-2016 (110 Index Points)
Figure Cost (USD) of Employing a Factory Worker
Table Average Price (USD/Unit) of Electricity to Ultimate Customers
Figure Manufacturing Process Analysis of Osteoarthritis Pain Drugs
Osteoarthritis Pain Drugs Information Industrial Chain Analysis
Table Raw Materials Sources of Osteoarthritis Pain Drugs Major Manufacturers in 2016
Table Major Buyers of Osteoarthritis Pain Drugs
Table Distributors/Traders List
Figure Global GDP Growth Rate for 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report